chr10-86452001-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_015045.5(WAPL):c.3080G>A(p.Gly1027Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015045.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WAPL | NM_015045.5 | c.3080G>A | p.Gly1027Asp | missense_variant | 15/19 | ENST00000298767.10 | |
WAPL | NM_001318328.2 | c.3062G>A | p.Gly1021Asp | missense_variant | 15/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WAPL | ENST00000298767.10 | c.3080G>A | p.Gly1027Asp | missense_variant | 15/19 | 1 | NM_015045.5 | P1 | |
WAPL | ENST00000372075.2 | c.807+1219G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251438Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135896
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727236
GnomAD4 genome AF: 0.000118 AC: 18AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.3080G>A (p.G1027D) alteration is located in exon 15 (coding exon 14) of the WAPL gene. This alteration results from a G to A substitution at nucleotide position 3080, causing the glycine (G) at amino acid position 1027 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at